Xổ số kiến thiết tuần thơProviding lifesaving technologies to cardiac surgery teams around the world
The Cardiovascular Division (Terumo Cardiovascular) manufactures and sells medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass and intra-operative monitoring.
A variety of Terumo products are used in cardiovascular surgery settings globally:
Among these, Terumo introduced the world’s first hollow fiber oxygenator in 1982. Through the years, Terumo has continually improved this technology to increase oxygen exchange performance and further reduce patient burden.
Recently, Terumo obtained manufacturing authorization for the world's first regenerative medicine product to treat heart failure – cell sheets derived from human skeletal muscle cells. Work continues to provide heart disease patients with this new treatment option.
Terumo Cardiovascular is committed to continuous innovation, pursuing less burdensome cardiovascular surgery to enhance cardiovascular patients’ quality of life.
Xổ số kiến thiết tuần thơNote: The regulatory approval status and availability of these products differ by country or region.
Xổ số kiến thiết tuần thơTerumo offers devices that circulate blood in place of the heart and lungs during cardiovascular surgery in which the heart is stopped (“on pump” surgery).
During open-heart surgery, the heart-lung machine temporarily takes over the pumping function of the heart.
An oxygenator temporarily takes over the functions of the lungs, exchanging gases including oxygen and then returning oxygenated blood back to the patient via the cardiopulmonary bypass circuit.
Note: Commercially available only in Japan and some Asian countries.
This system performs the heart and lung functions for a patient with life-threatening respiratory or cardiac failure. This is done by inserting a catheter into a blood vessel of the thigh to bring blood outside the body, where it is cycled through a centrifugal pump and membrane oxygenator in a closed state.
Xổ số kiến thiết tuần thơBeating Heart or Off-pump Coronary Artery Bypass Surgery avoids placing patients on-pump, and surgery is performed while the heart continues to beat. After chest incision, a stabilization system steadies only the portion of heart where the surgeon is working. This type of surgery is designed to avoid complications with on-pump procedures and benefits certain patient populations.
In 2015, Terumo’s HeartSheet autologous skeletal myoblast sheets became the world’s first cardiac regenerative therapy product to be approved for manufacture and sale. Individual skeletal myoblast sheets are made by taking skeletal myoblasts from the patient’s own thigh muscle, culturing them, and then forming them into sheets. These autologous skeletal myoblast sheets are transplanted directly onto the surface of the heart. They are seen as a promising therapy option for patients not likely to benefit from drug therapies or surgery.
Xổ số kiến thiết tuần thơRelated Links